News - Page 2 of 3

TenSkin™ – The perfect platform for microneedle applications.

Dr Paul Campbell gives his perspective on potential research avenues with TenSkin™. ‘Having worked directly with the company whilst on secondment over the past year, it’s been very interesting to assess which of the various skin-related research communities can benefit most from using TenSkin™, the human skin explant model developed by Ten Bio’, states Campbell. ‘The many proof-of-concept demonstrations that we’ve participated in, and now incidentally embodied with clarity in the latest company brochure, underscore the utter versatility of the…

Ten Bio is in Japan!

Ten Bio 社は日本にあります. In May this year, Ten Bio will attend the global session of the International Societies for Investigative Dermatology (ISID) to be held at the Keio Plaza Hotel, Tokyo between 10th and 13th of the month. This is a very exciting new geography for Ten Bio. The team will be hosting a booth to engage with the diverse set of delegates attending the meeting and is also to present on how mechanical tension influences the immuno-competency of ex…

TenSkin™ – the number one choice for skin research

Professor Giuseppe Valacchi has a global reputation for his work in expanding the understanding of cellular and molecular mechanisms that define the physio-pathological responses of skin tissue. In this interview, Professor Valacchi describes why TenSkinTM is his first choice for skin research and why he is pleased to lead Ten Bio’s Scientific Advisory Board . .

Spring Conference Season

As the Northern Hemisphere welcomes Spring 2023 the new season of industry conferences and symposia kicks off. And after the return to face to face meetings last year and the positive experiences had there, Ten Bio is very enthusiastic about our planned presence at a number of important events this year. Our schedule starts with our founders attending the PC Project Patient satellite meeting at the American Academy of Dermatology being held this year in the fabulous city of New…

Your Skin Research Partner – Ten Bio

service /ˈsəːvɪs/ Noun: ‘the action of helping or doing work for someone’ A note from the Chair Ten Bio’s early experience with our anchor clients has had a very significant effect on how the company now operates. Through placing client interaction at the forefront of our priorities, the nature of the interaction between client and service provider has rapidly evolved to become that of a trusted ‘research partner’. As a research partner Ten Bio has developed services optimized to leverage the…

Ten Bio named finalist in Scotland’s Life Science award.

Ten Bio is proud to announce that our company has been named one of three finalists in Scotland’s Life Science award in the category ‘Innovation – Pharma Services and Drug Discovery’. Scotland’s Life Sciences Annual Awards showcase eight prestigious awards recognising a range of achievements including skills development, innovation, investment, innovative collaboration, and business leadership. The innovation in pharma services and drug discovery award will be presented to an organisation that has been responsible for the creation of an…

Happy Holidays

Happy Holidays and thank you for following Ten Bio this year!

The origins of TenSkin™

Entering our third year since spin out, it’s time to celebrate the origins of our technology which has brought Ten Bio early success in a range of markets. The origin of our invention story stems from Robyn Hickerson, our co-founder and CEO, and her work at the University of Dundee. In the course of her research on the development of therapeutics for rare skin diseases, Robyn utilized various skin models. These included animal, cell-based and ex vivo models, but all…

‘When I was two, I was nearly new’ ….

‘When I was two I was nearly new’ … with thanks to A. A. Milne for the line from his 1927 poem ‘Now we are Six’.Ten Bio is not six, but we are two and ‘nearly new’ and celebrate the second anniversary of our launch in September this year. It has been a fascinating journey so far and with much more to come. I am very much looking forward to the success we will achieve on the journey to .…

Our differentiation in wound management….

In the previous note from the chairman I emphasized the potential role for Ten Bio in the area of wound management. My reason for that emphasis is simple: if you are evaluating how well a new approach / treatment can influence wound healing, then the key attribute of the test platform must be that it exhibits human skin’s normal response to wounding in vivo . . . or as close to ‘normal’ as can be achieved! Wound healing is a…